Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Malet-Martino

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|January 18, 2011
NMR techniques in biomedical and pharmaceutical analysisM Malet-Martino, U Holzgrabe
The Oncologist|August 20, 2002
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a reviewM Malet-Martino, R Martino
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
The prodrugs of 5-fluorouracilM Malet-Martino, P Jolimaitre, R Martino
Current Pharmaceutical Design|September 2, 1999
The analysis of cyclophosphamide and its metabolitesM Malet-Martino, V Gilard, R Martino
Current Drug Metabolism|July 24, 2001
Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugsR Martino, M Malet-Martino, V Gilard
Cellular and Molecular Biology (Noisy-Le-Grand, France)|July 1, 1997
A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolismC Loqueviel, M Malet-Martino, R Martino
The Analyst|September 1, 2017
Pulsed-field gradient nuclear magnetic resonance measurements (PFG NMR) for diffusion ordered spectroscopy (DOSY) mappingG Pagès, V Gilard, R Martino, et al.
Analytical and Bioanalytical Chemistry|May 4, 2010
Counterfeit drugs: analytical techniques for their identificationR Martino, M Malet-Martino, V Gilard, et al.
Revue Neurologique|October 26, 2001
[Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis]J Sabatier, D Ibarrola, M Malet-Martino, et al.
Current Drug Delivery|January 29, 2008
Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriersB Guidetti, J Azéma, M Malet-Martino, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Pharmaceutical and Biomedical Analysis|January 18, 2011
NMR techniques in biomedical and pharmaceutical analysisM Malet-Martino, U Holzgrabe
The Oncologist|August 20, 2002
Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a reviewM Malet-Martino, R Martino
Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
The prodrugs of 5-fluorouracilM Malet-Martino, P Jolimaitre, R Martino
Current Pharmaceutical Design|September 2, 1999
The analysis of cyclophosphamide and its metabolitesM Malet-Martino, V Gilard, R Martino
Current Drug Metabolism|July 24, 2001
Fluorine nuclear magnetic resonance, a privileged tool for metabolic studies of fluoropyrimidine drugsR Martino, M Malet-Martino, V Gilard
Cellular and Molecular Biology (Noisy-Le-Grand, France)|July 1, 1997
A 13C NMR study of 2-(13)C-chloroacetaldehyde, a metabolite of ifosfamide and cyclophosphamide, in the isolated perfused rabbit heart model. Initial observations on its cardiotoxicity and cardiac metabolismC Loqueviel, M Malet-Martino, R Martino
The Analyst|September 1, 2017
Pulsed-field gradient nuclear magnetic resonance measurements (PFG NMR) for diffusion ordered spectroscopy (DOSY) mappingG Pagès, V Gilard, R Martino, et al.
Analytical and Bioanalytical Chemistry|May 4, 2010
Counterfeit drugs: analytical techniques for their identificationR Martino, M Malet-Martino, V Gilard, et al.
Revue Neurologique|October 26, 2001
[Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis]J Sabatier, D Ibarrola, M Malet-Martino, et al.
Current Drug Delivery|January 29, 2008
Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriersB Guidetti, J Azéma, M Malet-Martino, et al.
Pageof 3